Related Posts

    Sorry, no posts matched your criteria.

Title Image


หน้าแรก   /   Products   /   VENBIG


(Human hepatitis B immunoglobulin)

• Prevention of hepatitis B virus recurrence after liver transplantation for hepatitis B virus induced liver failure in combination with antiviral therapy.
• Immunoprophylaxis of hepatitis B:
   - In case of accidental exposure in non-immunised subjects (including persons whose vaccination is incomplete or status unknown)
   - In haemodialysed patients, until vaccination has become effective
   - In the newborn of a hepatitis B virus carrier-mother
   - In subjects who did not show an immune response (no measurable hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.

เลขทะเบียน 1C 33/54 (NBC)

ฆศ. 1184/ 2563

เป็นยาใหม่ ใช้เฉพาะสถานพยาบาลแพทย์ควรติดตามผลการใช้ยา